PROTACs: A Paradigm Shift in Drug Discovery – Module 3
Program Overview
Navigating the Frontier of Hematologic Malignancy Therapies (3 of 5 Modules)
This activity provides an overview of emerging data in the development of proteolysis targeting chimeras (PROTACs) that harness intracellular E3-ubiquitin ligases for the treatment of hematologic malignancies.